Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

PARIS, FRANCE, 24 April 2024 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024.     Q1 2024  Q1 2023  % change  €m  €m  Actual CER1 Growth plat

By: financialpost.com

Apr 24 2024
113
6836 Views

PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. Read More

Bystander livestreams during Charlotte standoff show an ever-growing appetite for social media video

Township of Black River-Matheson and CUPE 1490 Reach Tentative Agreement and Return to Work Protocol

Kolibri Global Energy Inc. Revocation of Management Cease Trade Order

Anaergia Announces Additional Delay in the Filing of Its Audited Financial Statements and Related Disclosures

Boeing threatens to lock out its private firefighters around Seattle in a dispute over pay

Slate Office REIT Announces Voting Results from 2024 Meeting of Unitholders and Posts Q1 2024 Earnings Call Transcript and Investor Update

Galway Metals Announces Second Closing of Private Placement of Flow-Through Units

Ultra Lithium Provides Bi-Weekly Default Status Report

BetterLife Announces Intent to Complete Private Placement of Units

Safety lapses contributed to patient assaults at Oregon State Hospital, federal report says

Most actively traded companies on the Toronto Stock Exchange

AGF Reports April 2024 Assets Under Management and Fee-Earning Assets

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches